April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
The Somatostatin Analogue Octreotide Acts As A Vegf-c Stimulating Factor In Human Retinal Pigment Epithelium
Author Affiliations & Notes
  • Petrus M. Van Hagen
    Internal Medicine,
    Erasmus Medical Center, Rotterdam, The Netherlands
    The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • R W. Kuijpers
    Ophthalmology,
    Erasmus Medical Center, Rotterdam, The Netherlands
  • S Swagemakers
    Genetics,
    Erasmus Medical Center, Rotterdam, The Netherlands
  • T Missotten
    The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • F Staal
    Immunology,
    Erasmus Medical Center, Rotterdam, The Netherlands
  • G S. Baarsma
    The Rotterdam Eye Hospital, Rotterdam, The Netherlands
  • L J. Hofland
    Internal Medicine,
    Erasmus Medical Center, Rotterdam, The Netherlands
  • Footnotes
    Commercial Relationships  Petrus M. Van Hagen, Novartis Netherlands (R); R. W. Kuijpers, None; S. Swagemakers, None; T. Missotten, None; F. Staal, None; G. S. Baarsma, None; L. J. Hofland, Novartis Pharma (F, R)
  • Footnotes
    Support  SWOO-Flieringa 2001-20
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3356. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Petrus M. Van Hagen, R W. Kuijpers, S Swagemakers, T Missotten, F Staal, G S. Baarsma, L J. Hofland; The Somatostatin Analogue Octreotide Acts As A Vegf-c Stimulating Factor In Human Retinal Pigment Epithelium. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3356.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinal pigment epithelium (RPE) has numerous functions that maintain the integrity and function of photoreceptors. Previously, we have shown that RPE cells express the somatostatin receptor subtypes (sst) 1 and 2. Moreover, sst2 activating drugs have been used in the treatment of retinal diseases such as diabetes, macular degeneration, retinitis pigmentosa and macular edema. In this study we investigated the effect of the sst2 agonist octreotide in RPE on cell growth, gene expression profiles and growth factor and cytokine synthesis/secretion.

Methods: : Primary RPE cells were stably transduced with sst2a- LZRS-IRES-Lyt2a and incubated in DMEM with and without octreotide. Intracellular calcium flux experiments were used to confirm functionality of sst2. At time points 0 (baseline), 6 and 24 hours, gene-profile (Affymetrix, Santa Clara, CA) and growth factor and cytokine synthesis (RayBiotech, Norcross GA) were measured. Data analysis was performed with Partek and Treescape OmniViz. Cell proliferation was measured using whole DNA analysis and VEGF was measured by ELISA.

Results: : Gene expression profiles at 6 hrs and 24 hrs showed a change in expression of respectively 2870 and 249 genes (p<0.05) or 819 and 0 genes (p<0.01). Combined analysis of micro-array data at 6 hrs and growth factor and cytokine secretion spectrum at 24 hrs showed an increased VEGF-C expression/secretion pattern (and plasminogen activator/urokinase receptor and inhibin beta A). Co-culture of RPE cells with octreotide showed an increase secretion ratio VEGF/DNA from 0.4 to 1.2 pg/ng.

Conclusions: : Combined gene expression profiles, protein blot results and culture experiments showed that octreotide stimulates VEGF(-C) production by RPE cells.

Keywords: retinal pigment epithelium • neuropeptides • vascular endothelial growth factor 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×